跳至主要内容
临床试验/ISRCTN12245727
ISRCTN12245727已完成不适用

Four year follow-up of a randomised controlled trial of joint protection for people with rheumatoid arthritis (RA)

Arthritis Research Campaign (ARC) (UK)0 个研究点目标入组 0 人开始时间: 2002年7月12日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Adult patients with diagnosis of rheumatoid arthritis
  • 2. Wrist and or metacarpophalangeal joint disease currently or recently (within previous 6 months) affecting hand function
  • 3. Currently experiencing hand pain on activity
  • 4. Up to 5 years disease duration

排除标准

  • Not provided at time of registration

研究者

发起方
Arthritis Research Campaign (ARC) (UK)

相似试验

已完成
2 期
follow up of Effects of Melatonin on Fatigue Associated associated with radiotherapy and chemotherapy
IRCT20180426039421N3Hamedan University of Medical Sciences64
已完成
4 期
Six year follow up of children at high hereditary risk of allergy born to mothers participating in the DOMInO Trial.Atopy & Allergic DiseaseInflammatory and Immune System - AllergiesAlternative and Complementary Medicine - Other alternative and complementary medicineInflammatory and Immune System - Normal development and function of the immune system
ACTRN12615000498594Women's & Children's Health Research Institute668
尚未招募
不适用
Mid-term follow-up of a randomized controlled trial comparing ultrasound-guided double percutaneous needling versus high-energy extracorporeal shockwave therapy in the treatment of calcific tendinitis of the rotator cuff.
NL-OMON51922Spaarne Gasthuis81
招募中
4 期
Evaluating a full or fractional third dose Covid-19 vaccines in previously vaccinated adultsCovid-19C01.748
RBR-4vmh6xgCentro de Estudos e Pesquisas em Moléstias Infecciosas LTDA - CePCLI
进行中(未招募)
4 期
Evaluating a full or fractional third dose of COVID-19 vaccines in previously vaccinated adultsThe administration of fractional dose of Pfizer/Wyeth or AstraZeneca/Fiocruz vaccines for prevention of COVID-19 when used as an additional dose in adults aged 18 years or older who have received 2 doses of Sinovac/Butantan, at least 4 months (120 days) prior to administration of booster.Infections and Infestations
ISRCTN47074508niversity of Oxford700